Patents

US 8207170 B2: Heterocyclic substituted piperazines with CXCR3 antagonist activity

Granted
2012-06-26
Filed
2010-11-23 application 12952994
Type
Utility · 1 claim
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1:or a pharmaceutically acceptable salt, solvate or ester thereof, wherein the various moieties are defined herein. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.g, tuberculoid leprosy), fixed drug eruptions, cutaneous delayed-type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.

Source: PVGPATDIS, file of 2026-04-10 (ipg120626.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
SCHERING CORPORATION 216 patentsUS company or organizationKenilworth, NJSCHERING CORPORATION State business registration EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10
Pharmacopeia Drug Discovery, Inc. 12 patentsUS company or organizationPrinceton, NJPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Seong Heon KimLivingston, NJ15PVGPATDIS, file of 2026-04-10
Gopinadhan N. AnilkumarEdison, NJ7PVGPATDIS, file of 2026-04-10
Michael K. C. WongNew Brunswick, NJ16PVGPATDIS, file of 2026-04-10
Qingbei ZengEdison, NJ20PVGPATDIS, file of 2026-04-10
Stuart B. RosenblumWest Orange, NJ21PVGPATDIS, file of 2026-04-10
Joseph A. KozlowskiPrinceton, NJ67PVGPATDIS, file of 2026-04-10
Yuefei ShaoPrinceton, NJ5PVGPATDIS, file of 2026-04-10
Brian F. McGuinnessPlainsboro, NJ16PVGPATDIS, file of 2026-04-10
Douglas W. HobbsYardley, PA9PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D401/12PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/04PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-08Merger
Merger
MERCK SHARP & DOHME CORP. signed 2022-04-07MERCK SHARP & DOHME LLC RAHWAY, NJ61102/145PASDL, file of 2026-10-15
2012-08-30Name change
Change of name
SCHERING CORPORATION signed 2012-05-02MERCK SHARP & DOHME CORP. RAHWAY, NJ28884/151PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.